Published 1 year ago • loading... • Updated 11 months ago
TMCI DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Treace Medical Concepts, Inc. ...
On May 27, 2025, the Rosen Law Firm initiated a class action lawsuit in San Diego on behalf of investors who purchased shares of DoubleVerify Holdings, Inc., traded on the New York Stock Exchange under the ticker DV, during the period from early November 2023 through late February 2025.
The lawsuit arises from allegedly false and misleading statements about DoubleVerify’s advertising technology limits on closed platforms and its impaired ability to compete and monetize Activation Services.
DoubleVerify's clients redirected their advertising budgets away from open marketplaces toward proprietary platforms, where the company faced technological limitations, heightened competition from native platform tools, reduced profitability, and prolonged delays in generating revenue.
The lawsuit alleges that DoubleVerify charged its clients for advertising impressions generated by bots and that the company's risk disclosures were consistently inaccurate and deceptive during the class period.
Investors who bought DoubleVerify’s stock during the class period may seek compensation without out-of-pocket fees under a contingency fee arrangement handled by Rosen Law Firm, a recognized securities litigation firm.